Revenue

Amphastar beats Q2 estimates with new drug sales, but a deeper look reveals pricing pressure, rising costs, and a high-stakes bet on its pipeline.

Genpact's stellar Q2 results are more than just numbers; they're proof of a strategic pivot to 'Agentic Operations' that could reshape the BPO landscape.

A reported net loss obscures core growth at 10x Genomics. An acquisition, key partnerships, and a blockbuster product launch signal a decisive strategic pivot.

After Commerce.com's dismal Q2 results and stock plunge, AI-native rival Rezolve Ai declares its rejected merger proposal was the right path all along.

A startup led by ex-Novo Nordisk execs plans a reverse takeover to fund its made-in-Canada generic Ozempic, aiming to disrupt a C$3.5B market.

Beyond a top global ranking, BC Place is leveraging record event growth to drive hundreds of millions in economic impact and redefine Vancouver's world stage.

As Intchains prepares its H1 2026 report, it's not just financials on the line. It's a test of a bold strategy to build a Web3 ecosystem beyond Bitcoin.

The sale of Smith + Howard from one PE firm to another reveals the new formula for growth: aggressive M&A, AI, and global talent. Here's the inside story.

With a new CFO and a massive infusion of public and private cash, Multibeam is scaling up. Here’s how its unique tech is becoming a cornerstone of the US CHIPS Act.

Where Food Comes From boosts profits via efficiency and new certifications like RaiseWell, offsetting beef market pressures and digital asset swings.

One specialty clinic cut no-shows by 85% and grew a key program by 600%. We analyze the numbers, the tech, and the strategy behind the hype.

A union vote at a Rochester EMS agency reveals deep-seated issues of pay and respect, setting the stage for a critical test of financial and operational strategy.

As Birchtech preps for its Q2 earnings, the market is watching. Its PFAS-fighting tech is promising, but can it fix a battered stock and prove its path to profit?

Facing financial headwinds, the energy storage firm's secret deal could be a brilliant strategic pivot or a desperate gambit for survival in a rapidly changing sector.

iSpecimen's new $5M offering aims to fix its balance sheet and fund expansion. But in a tough market, is this a strategic reset or a temporary patch?

Onfolio Holdings is betting on a 1-for-50 reverse split to save its Nasdaq listing. But is it a lifeline or a red flag for a company facing deeper issues?

A successful pilot with a top insurer shows Inuvo’s privacy-first AI can find new customers by decoding intent, signaling a shift from reach to relevance.

Delcath Systems posts strong revenue and profits, but the real story is its massive investment in expanding its unique liver therapy to fight breast cancer and more.

The media giant posts a second straight profitable quarter, but a closer look reveals a strategy built on deep cuts and a shrinking user base.

Tejon Ranch flipped a loss into a $2.6M profit by cutting costs and doubling down on industrial real estate. But is this disciplined focus enough to fund its massive future?